Effect of everolimus treatment on chromogranin A, neuron-specific enolase, gastrin, and glucagon levels in patients with advanced pancreatic neuroendocrine tumors (pNET): Phase III RADIANT-3 study results.
Elisabeth De Vries
Consultant or Advisory Role - Novartis (U)
Research Funding - Novartis (I)
Lowell Anthony
No relevant relationships to disclose
Lucas Sideris
Research Funding - AstraZeneca; Novartis; Roche; Sanofi
Li-Tzong Chen
Consultant or Advisory Role - Novartis (U)
Honoraria - Novartis
Research Funding - Novartis
Jeremie Lebrec
Employment or Leadership Position - Novartis
Zenta Tsuchihashi
Employment or Leadership Position - Novartis
Robert Winkler
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
James Yao
Consultant or Advisory Role - Endo Pharmaceuticals; Ipsen; Novartis; Pfizer
Honoraria - Novartis
Research Funding - Genentech; Novartis
Kjell Oberg
Consultant or Advisory Role - Ipsen; Novartis; Pfizer
Honoraria - Ipsen; Novartis; Pfizer
Other Remuneration - Novartis